The Egl Nine Homolog 1 pipeline drugs market research report outlays comprehensive information on the Egl Nine Homolog 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Egl Nine Homolog 1 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Hematological Disorders, Toxicology, Gastrointestinal, and Ophthalmology which include the indications Anemia in Chronic Kidney Disease (Renal Anemia), Sickle Cell Disease, Chemotherapy Induced Anemia, Ulcerative Colitis, Inflammatory Bowel Disease, and Retinopathy. It also reviews key players involved in Egl Nine Homolog 1 targeted therapeutics development with respective active and dormant or discontinued products.
The Egl Nine Homolog 1 pipeline targets constitutes close to six molecules. Out of which, approximately four molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Pre-Registration, Phase III, Phase I, and IND/ CTA Filed stages are 1, 1, 1, and 1 respectively. Similarly, the universities portfolio in Preclinical comprises 1 molecule.
Egl Nine Homolog 1 overview
Egl Nine Homolog 1 is a cellular oxygen sensor under normoxic conditions it catalyzes the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins. Hydroxylates a specific proline found in each of the oxygen-dependent degradation (ODD) domains (N-terminal, NODD, and C-terminal, CODD) of HIF1A. Also hydroxylates HIF2A.
For a complete picture of Egl Nine Homolog 1’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.